Niva Bupa Health Insurance launched Meridian, an International Private Medical Insurance product, on Wednesday (18 November 2026). The offering targets globally mobile professionals, NRIs and internationally connected families, providing coverage across domestic and international markets.

Servicing and claims handling will involve Niva Bupa managing Indian claims, Bupa Global handling those outside India (excluding the US), and Blue Cross Blue Shield managing claims in the US. The company disclosed the launch to stock exchanges under SEBI Regulation 30 on the same day.
Separately, Niva Bupa sought shareholder approval through a postal ballot to nearly double its ESOP pool from 3.82 crore to 7.72 crore options. E-voting opens on 19 November 2026 and closes on 18 December 2026.
Hindu Business Line leads with the international partnership and service structure, featuring executive quotes from Niva Bupa and Bupa Global about borderless healthcare. Scanx.trade frames the same launch as a regulatory disclosure, a SEBI filing with product details and investor data. Where Business Line emphasises customer benefits and global access, Scanx.trade strips the story to compliance and historical stock returns. Both report neutrally but choose different primary audiences: Business Line speaks to readers, Scanx.trade to shareholders. The balanced reading is that Niva Bupa formally entered global health insurance via a SEBI-compliant filing, with a high-profile partnership that the filing itself does not name.
Coverage: 2 sources, 2 neutral
Sources (2): thehindubusinessline.com (neutral report), scanx.trade (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.